Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Gastrointestinal Medicine
Volume 2017, Article ID 2416901, 3 pages
https://doi.org/10.1155/2017/2416901
Case Report

Mirrizi Syndrome and Markedly Elevated Levels of Carbohydrate Antigen 19-9 in the Absence of Malignant Disease

University of Illinois at Chicago/Christ Hospital Advocate Medical Center, Oak Lawn, IL, USA

Correspondence should be addressed to Natasha Shah; moc.liamg@94ahsatan.hahs

Received 1 December 2016; Accepted 10 April 2017; Published 26 April 2017

Academic Editor: Hideto Kawaratani

Copyright © 2017 Natasha Shah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Maestranzi, R. Przemioslo, H. Mitchell, and R. A. Sherwood, “The effect of benign and malignant liver disease on the tumour markers CA19-9 and CEA,” Annals of Clinical Biochemistry, vol. 35, no. 1, pp. 99–103, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Mathurin, J.-F. Cadranel, D. Bouraya et al., “Marked increase in serum CA 19-9 level in patients with alcoholic cirrhosis: report of four cases,” European Journal of Gastroenterology and Hepatology, vol. 8, no. 11, pp. 1129–1131, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Safi, H. G. Beger, R. Bittner, M. Büchler, and W. Krautzberger, “CA 19-9 and pancreatic adenocarcinoma,” Cancer, vol. 57, no. 4, pp. 779–783, 1986. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Steinberg, “The clinical utility of the CA 19.9 tumor-associated antigen,” Case Reports in Gastrointestinal Medicine, vol. 85, pp. 350–355, 1990. View at Google Scholar
  5. D. Marrelli, S. Caruso, C. Pedrazzani et al., “CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions,” American Journal of Surgery, vol. 198, no. 3, pp. 333–339, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. E. De Goede and S. Yap, “An exceptional high concentration of serum CA 19.9 in a patient with alcoholic liver disease Department of Hepatology, University Hospital Leuven,” Gut, vol. 41, no. 4, pp. 577–580, 1997. View at Publisher · View at Google Scholar
  7. G. Bertino, A. M. Ardiri, G. S. Calvagno et al., “Carbohydrate 19.9 antigen serum levels in liver disease,” BioMed Research International, vol. 2013, Article ID 531640, 6 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Schöniger-Hekele and C. Müller, “The combined elevation of tumor markers CA 19-9 and CA 125 in liver disease patients is highly specific for severe liver fibrosis,” Digestive Diseases and Sciences, vol. 51, no. 2, pp. 338–345, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Ventrucci, P. Pozzato, A. Cipolla, and G. Uomo, “Persistent elevation of serum CA 19-9 with no evidence of malignant disease,” Digestive and Liver Disease, vol. 41, no. 5, pp. 357–363, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Basso, T. Meggiato, C. Fabris et al., “Extra-hepatic cholestasis determines a reversible increase of glycoproteic tumour markers in benign and malignant diseases,” European Journal of Clinical Investigation, vol. 22, no. 12, pp. 800–804, 1992. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Milone, M. Musella, P. Maietta et al., “Acute acalculous cholecystitis determining Mirizzi syndrome: case report and literature review,” BMC Surgery, vol. 14, article no. 90, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. U. Gibor, Z. H. Perry, U. Netz et al., “CA 19-9 in the presence of obstructive jaundice due to mirizzi syndrome,” Israel Medical Association Journal, vol. 17, no. 1, pp. 60–61, 2015. View at Google Scholar · View at Scopus
  13. R. Peterli, B. Meyer-Wyss, U. Herzog et al., “CA19-9 has no value as a tumor marker in obstructive jaundice,” Case Reports in Gastrointestinal Medicine, vol. 129, no. 3, pp. 77–79, 1999. View at Google Scholar